Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

Literature DB >> 27655060

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

Mari Mino-Kenudson¹.

Abstract

Year: 2016 PMID： 27655060 PMCID： PMC5009080 DOI： 10.21037/tlcr.2016.08.01

Source DB: PubMed Journal: Transl Lung Cancer Res ISSN： 2218-6751

× No keyword cloud information.

19 in total

Review 1. Cell-free nucleic acids as biomarkers in cancer patients.

Authors: Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal: Nat Rev Cancer Date: 2011-05-12 Impact factor: 60.716

Review 2. Circulating nucleic acids (CNAs) and cancer--a survey.

Authors: M Fleischhacker; B Schmidt
Journal: Biochim Biophys Acta Date: 2006-10-07

3. Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Authors: Lynette M Sholl; Dara L Aisner; Timothy Craig Allen; Mary Beth Beasley; Philip T Cagle; Vera L Capelozzi; Sanja Dacic; Lida P Hariri; Keith M Kerr; Sylvie Lantuejoul; Mari Mino-Kenudson; Kirtee Raparia; Natasha Rekhtman; Sinchita Roy-Chowdhuri; Eric Thunnissen; Ming Tsao; Marina Vivero; Yasushi Yatabe
Journal: Arch Pathol Lab Med Date: 2016-05-19 Impact factor: 5.534

4. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

Authors: Geoffrey R Oxnard; Cloud P Paweletz; Yanan Kuang; Stacy L Mach; Allison O'Connell; Melissa M Messineo; Jason J Luke; Mohit Butaney; Paul Kirschmeier; David M Jackman; Pasi A Jänne
Journal: Clin Cancer Res Date: 2014-01-15 Impact factor: 12.531

5. Tumor self-seeding by circulating cancer cells.

Authors: Mi-Young Kim; Thordur Oskarsson; Swarnali Acharyya; Don X Nguyen; Xiang H-F Zhang; Larry Norton; Joan Massagué
Journal: Cell Date: 2009-12-24 Impact factor: 41.582

6. Plasma T790M Result Alters Treatment Options in a Previously T790 Wild-Type EGFR-Mutant Lung Cancer.

Authors: Zofia Piotrowska; Benjamin Drapkin; Jeffrey A Engelman; Rebecca J Nagy; Richard B Lanman; Lecia V Sequist
Journal: J Thorac Oncol Date: 2016-04-12 Impact factor: 15.609

7. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.

Authors: Richard B Lanman; Stefanie A Mortimer; Oliver A Zill; Dragan Sebisanovic; Rene Lopez; Sibel Blau; Eric A Collisson; Stephen G Divers; Dave S B Hoon; E Scott Kopetz; Jeeyun Lee; Petros G Nikolinakos; Arthur M Baca; Bahram G Kermani; Helmy Eltoukhy; AmirAli Talasaz
Journal: PLoS One Date: 2015-10-16 Impact factor: 3.240

Review 8. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.

Authors: Jie Luo; Li Shen; Di Zheng
Journal: Sci Rep Date: 2014-09-09 Impact factor: 4.379

9. EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

Authors: Kenneth S Thress; Roz Brant; T Hedley Carr; Simon Dearden; Suzanne Jenkins; Helen Brown; Tracey Hammett; Mireille Cantarini; J Carl Barrett
Journal: Lung Cancer Date: 2015-10-09 Impact factor: 5.705

10. Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.

Authors: Qiang Pu; Yuchuan Huang; Yanrong Lu; Yong Peng; Jie Zhang; Guanglin Feng; Changguo Wang; Lunxu Liu; Ya Dai
Journal: Thorac Cancer Date: 2016-02-01 Impact factor: 3.500

10 in total

1. Commentary on tumor heterogeneity.

Authors: Helmut H Popper
Journal: Transl Lung Cancer Res Date: 2016-08

Review 2. Liquid Biopsy in Tumor Genetic Diagnosis.

Authors: Andreas Jung; Thomas Kirchner
Journal: Dtsch Arztebl Int Date: 2018-03-09 Impact factor: 5.594

3. Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer.

Authors: Jhanelle E Gray; Isamu Okamoto; Virote Sriuranpong; Johan Vansteenkiste; Fumio Imamura; Jong Seok Lee; Yong-Kek Pang; Manuel Cobo; Kazuo Kasahara; Ying Cheng; Naoyuki Nogami; Eun Kyung Cho; Wu Chou Su; Guili Zhang; Xiangning Huang; Xiaocheng Li-Sucholeiki; Brian Lentrichia; Simon Dearden; Suzanne Jenkins; Matilde Saggese; Yuri Rukazenkov; Suresh S Ramalingam
Journal: Clin Cancer Res Date: 2019-08-22 Impact factor: 12.531

Review 4. Microscale nonlinear electrokinetics for the analysis of cellular materials in clinical applications: a review.

Authors: Blanca H Lapizco-Encinas
Journal: Mikrochim Acta Date: 2021-03-02 Impact factor: 5.833

5. Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.

Authors: Young Joon Byun; Xuan Mei Piao; Pildu Jeong; Ho Won Kang; Sung Phil Seo; Sung Kwon Moon; Jong Young Lee; Yung Hyun Choi; Hee Youn Lee; Won Tae Kim; Sang Cheol Lee; Eun Jong Cha; Seok Joong Yun; Wun Jae Kim
Journal: Investig Clin Urol Date: 2021-03-16

6. Characterization of Factors Affecting the Detection Limit of EGFR p.T790M in Circulating Tumor DNA.

Authors: Ibrahim Fahoum; Relly Forer; Dina Volodarsky; Inna Vulih; Tova Bick; Shada Sarji; Zeev Bamberger; Ofer Ben-Izhak; Edmond Sabo; Ruth Hershberg; Dov Hershkovitz
Journal: Technol Cancer Res Treat Date: 2018-01-01

Review 7. The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic.

Authors: Sudeh Izadmehr; Dara J Lundon; Nihal Mohamed; Andrew Katims; Vaibhav Patel; Benjamin Eilender; Reza Mehrazin; Ketan K Badani; John P Sfakianos; Che-Kai Tsao; Peter Wiklund; William K Oh; Carlos Cordon-Cardo; Ashutosh K Tewari; Matthew D Galsky; Natasha Kyprianou
Journal: Front Oncol Date: 2021-09-27 Impact factor: 6.244